Down-regulating NQO1 promotes cellular proliferation in K562 cells via elevating DNA synthesis

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• NAD(P)H:quinone oxidoreductase 1 (NQO1) is a protective enzyme involved in redox regulation.
• Emerging roles of NQO1 include regulation of tumor cell proliferation, with links to chronic myeloid leukemia (CML).
• Mechanisms of NQO1's influence on leukemia progression are not fully understood.

Purpose of the Study:

• To identify NQO1 as a novel molecular target for modulating DNA synthesis and CML growth.
• To investigate the functional impact of NQO1 activity on leukemia cell proliferation and tumorigenesis.

Main Methods:

• Analysis of NQO1 polymorphism frequency in CML patients versus healthy individuals.
• Experimental NQO1 knockdown and overexpression in K562 CML cells.
• Assessment of DNA synthesis markers, including TOP2A and MCM complex expression.
• Evaluation of tumorigenesis in a xenograft model.

Main Results:

• The T allele of NQO1 polymorphism is more frequent in East Asian CML patients than in healthy controls.
• NQO1 knockdown significantly increased TOP2A and MCM complex protein expression, enhancing DNA synthesis and K562 cell growth.
• NQO1 knockdown promoted tumorigenesis in vivo, while NQO1 overexpression showed opposite effects.

Conclusions:

• NQO1 downregulation promotes K562 cell proliferation by elevating DNA synthesis.
• NQO1 activity is a critical regulator of CML cell growth and DNA replication.
• NQO1 represents a potential therapeutic target for CML treatment.